226
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Development, Characterization, and Evaluation of Celecoxib Microemulsion for Topical Delivery

&
Pages 1411-1418 | Received 11 Jul 2011, Accepted 14 Aug 2011, Published online: 27 Sep 2012
 

Abstract

In the present research, the potential of topical microemulsion delivery of poorly aqueous soluble drug, that is, Celecoxib, was investigated. Microemulsions are regarded as highly biocompatible topical carrier systems for the delivery of several anti-inflammatory, local anesthetics, anti-infective drugs. Microemulsion vehicles composed of various proportions of oleic acid, Lipoid E80, and Capryol 90/PEG 400 as oil phase, surfactant, and cosurfactant phase, respectively. A pseudo-ternary phase diagram was constructed at room temperature by titration method, and the oil-to-surfactant/co-surfactant volume ratios (O/SC) that exhibit the maximum solubilization of water were determined. Microemulsion formulations were physically characterized for globule size, thermal stability, centrifugation stress testing, specific gravity, pH, and in vitro permeation studies on rat abdominal skin. The permeation data showed that microemulsion formulation, ME-2, showed increased Celecoxib flux to several-fold over the control vehicle, that is, the self-prepared gel formulation. It was concluded from the above studies that microemulsions could be a promising dosage form to improve drug stability in topical formulations.

Acknowledgments

The authors are grateful to Arbro Pharmaceuticals Pvt. Ltd., New Delhi, for providing the gift samples of Celecoxib; College of Pharmaceutical Sciences, Raj Kumar Goel Institute of Technology, Ghaziabad, UP, India, for providing all the necessary research facilities; and SMITA Research Labs, IIT Delhi for the particle size analyzer. The authors also thanks to Gattefosse, France, for providing the gift sample of cosurfactant.

Notes

a Mean ± SD, n = 6.

Mean ± SD, n = 3.

a Mean ± SD, n = 3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.